(Q80775201)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17689842%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

In vitro interactions between macrophages and aluminum-containing adjuvants (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17689842%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Anne-Cécile Rimaniol

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17689842%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Gabriel Gras

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17689842%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Pascal Clayette

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17689842%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

16 July 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17689842%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17689842%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17689842%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

37-38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17689842%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

6784-6792

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17689842%20AND%20SRC:MED&resulttype=core&format=json

Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle

3 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.051

Aluminium assay and evaluation of the local reaction at several time points after intramuscular administration of aluminium containing vaccines in the Cynomolgus monkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.051

Immunization with the adjuvant MF59 induces macrophage trafficking and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.051

Adhesion molecule-dependent mechanisms regulate the rate of macrophage clearance during the resolution of peritoneal inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.051

(How) do aluminium adjuvants work?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.051

The Common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.051

Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.051

AlOH3-adjuvanted vaccine-induced macrophagic myofasciitis in rats is influenced by the genetic background.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.051

Cytokine mRNA levels in unmanipulated (ex vivo) and in vitro stimulated monkey PBMCs using a semi-quantitative RT-PCR and high sensitivity fluorescence-based detection strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.051

MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.051

Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.051

A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.051

Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.051

CD83 is an I-type lectin adhesion receptor that binds monocytes and a subset of activated CD8+ T cells [corrected].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.051

Either IL-2 or IL-12 is sufficient to direct Th1 differentiation by nonobese diabetic T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.051

CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.051

Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.051

The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.051

Cutting edge: CD83 regulates the development of cellular immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.051

The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.051

7 January 2021

The B7-CD28 superfamily

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.051

The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.051

Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.051

Vesicle size influences the trafficking, processing, and presentation of antigens in lipid vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.051

Promotion of B cell immune responses via an alum-induced myeloid cell population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.051

MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.051

MF59 adjuvant enhances the antibody response to recombinant hepatitis B surface antigen vaccine in primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.06.051

10.1016/J.VACCINE.2007.06.051

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17689842%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference